Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Revenue

Indo-Bangla Pharmaceuticals had revenue of 50.45M BDT in the quarter ending December 31, 2025, with 84.84% growth. This brings the company's revenue in the last twelve months to 221.18M, up 150.43% year-over-year. In the fiscal year ending June 30, 2025, Indo-Bangla Pharmaceuticals had annual revenue of 184.18M with 4.27% growth.

• Revenue (ttm): 221.18M
• Revenue Growth: +150.43%
• P/S Ratio: 6.83
• Revenue / Employee: 1.74M
• Employees: 127
• Market Cap: 1.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	184.18M	7.54M	4.27%
Jun 30, 2024	176.64M	-197.84M	-52.83%
Jun 30, 2023	374.48M	-110.20M	-22.74%
Jul 1, 2022	484.68M	-297.56M	-38.04%
Jul 1, 2021	782.24M	-83.86M	-9.68%